Compression Therapy Market - Global Forecasts to 2030
商品番号 : SMB-4812
出版社 | MarketsandMarkets |
出版年月 | 2025年5月 |
ページ数 | 279 |
図表数 | 293 |
価格タイプ | シングルユーザライセンス |
価格 | USD 4,950 |
種別 | 英文調査報告書 |
本市場調査では、圧迫療法市場を製品、技術、用途、流通チャネル、地域別にセグメント化し、分析しています。市場に影響を与える主要な要因(牽引要因、制約要因、機会、課題など)に関する洞察を提供しています。
本レポートでは、ステークホルダーにとっての機会と課題を浮き彫りにし、主要な市場プレーヤーに焦点を当てた競争環境の詳細な分析を提供しています。さらに、マイクロマーケットについてもより詳細に分析し、成長パターン、機会、そして圧迫療法市場全体への貢献について考察しています。また、様々な市場セグメントの収益予測を掲載し、5つの主要地域における成長機会を特定しています。
The compression therapy market is expected to experience significant growth, increasing from USD 4.5 billion in 2025 to USD 5.9 billion by 2030, at a CAGR of 5.5%.
圧迫療法市場は、2025 年の 45 億米ドルから 2030 年には 59 億米ドルに増加し、年平均成長率 5.5% で大幅に成長すると予想されています。

This expansion is driven by several factors, including a growing elderly population, a notable rise in chronic venous insufficiency cases, and an increase in lymphedema related to cancer treatments. Additionally, the prevalence of sedentary lifestyles and rising obesity rates has led to a surge in circulatory disorders, creating a higher demand for non-invasive treatment options.
Improvements in product comfort, the development of discreet wearable designs, and increased clinical awareness among physicians have further contributed to the adoption of compression therapy in outpatient and home settings. These trends, along with wider reimbursement coverage in key markets, continue to bolster global market growth.
“Compression garments dominated the market in 2024.”
Compression garments lead the compression therapy market due to their extensive use in treating conditions like varicose veins, lymphedema, and chronic venous insufficiency. These products, including stockings, sleeves, and wraps, are popular because they are easy to use, available in various compression levels, and suitable for clinical settings and home care. Their increasing importance in post-surgical recovery and preventive care for at-risk populations, such as the elderly and those with sedentary lifestyles, has further driven demand. Additionally, ongoing innovations in product design, including the use of more breathable and comfortable fabrics, support their continued dominance in the market.
“The hospitals & clinics segment held the largest share of the compression therapy market in 2024.”
Hospitals & clinics are the primary distribution channels in the compression therapy market, especially for specialty products such as pneumatic compression devices and advanced therapeutic stockings. These medical facilities play a crucial role in treating conditions like chronic venous insufficiency, lymphedema, and post-surgical recovery. The prescriptions and recommendations made by physicians in clinical settings are vital for driving demand for compression therapy products. The growing clinical acceptance and well-established benefits of compression therapy contribute to its widespread use in these environments. Consequently, hospitals & clinics stand out as the leading distribution channels.

“The Asia Pacific regional segment is expected to register the highest CAGR in the compression therapy market during the forecast period.”
The growth in this market is driven by several factors, including an aging population in Japan and China, where venous and lymphatic issues are becoming more prevalent. Additionally, rising healthcare awareness and improvements in medical infrastructure in emerging economies like India are contributing to the increased use of compression therapy. Economic growth in the region is also elevating disposable incomes, enabling more individuals to access and afford these therapeutic products. Together, these trends, along with a growing acceptance of preventive care and post-surgical treatment, are accelerating market growth in the Asia Pacific (APAC) region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
- By Designation: C-level Executives (35%), Director-level Executives (25%), and Others (40%)
- By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)
Prominent players in the compression therapy market include 3M (US), BSN Medical (Germany), medi GmbH & Co. KG (Germany), Sigvaris AG (Switzerland), Juzo GmbH (Germany), Lohmann & Rauscher GmbH & Co. KG (Germany), DJO Global (US), JOBST (US), Therafirm (US), Bauerfeind AG (Germany), PAUL HARTMANN AG (Germany), CircAid Medical Products, Inc. (US), Tactile Medical (US), Bio Compression Systems, Inc. (US), THUASNE (France), among others.

Research Coverage
This market research analyzes the compression therapy market by segmenting it according to product, technique, application, distribution channel, and region. It provides insights into key factors influencing the market, including drivers, restraints, opportunities, and challenges. The report highlights opportunities and challenges for stakeholders and offers a detailed analysis of the competitive landscape, focusing on major market players. Additionally, it examines the micromarkets in greater detail, looking at growth patterns, opportunities, and their contributions to the overall compression therapy market. The report also includes revenue generation forecasts for various market segments and identifies growth opportunities across five key regions.
Key Benefits of Buying this Report
This report is valuable for both new and current players in the market, offering essential information to identify potential investment opportunities. It provides a comprehensive overview of both major and minor players, facilitating effective risk analysis and informed investment decisions. The report includes precise segmentation based on end users and geographical regions, offering detailed insights into niche market segments. Additionally, it highlights key trends, challenges, growth drivers, and opportunities, supporting strategic decision-making through a balanced analysis.
Through this report, readers get insightful views into the following parameters:
The compression therapy market is experiencing growth driven by several key factors, including the increasing prevalence of chronic conditions such as venous insufficiency and lymphedema, which require long-term management. Advances in automated diagnostic tools and smart compression devices are enhancing treatment efficiency and accuracy.
However, high product costs and a lack of awareness in emerging markets constrain this growth. However, there are also significant opportunities for the market, such as product innovation in areas like antimicrobials and custom-fit solutions. Market diversification through new product launches and expansions into untapped regions could further propel growth in the compression therapy market.
- Product Development/Innovation: Emerging technologies, ongoing R&D activities, and recent launches of products in the market
- Market Development: The report has elaborated the markets by segmenting the compression therapy market into different regions
- Market Diversification: New product launches, unexploited markets, recent developments, and investments in the compression therapy market
- Competitive Analysis: A comprehensive analysis of market share, product offerings, and leading strategies of major players, such as 3M (US), BSN Medical (Germany), medi GmbH & Co. KG (Germany), Sigvaris AG (Switzerland), Juzo GmbH (Germany), Lohmann & Rauscher GmbH & Co. KG (Germany), DJO Global (US), JOBST (US), Therafirm (US), Bauerfeind AG (Germany), PAUL HARTMANN AG (Germany), CircAid Medical Products, Inc. (US), Tactile Medical (US), Bio Compression Systems, Inc. (US), and THUASNE (France)
Table of Contents
1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 STUDY SCOPE 26
1.3.1 MARKETS COVERED & REGIONAL SCOPE 26
1.3.2 INCLUSIONS & EXCLUSIONS 27
1.3.3 YEARS CONSIDERED 27
1.4 CURRENCY CONSIDERED 28
1.5 STAKEHOLDERS 28
1.6 SUMMARY OF CHANGES 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.1.1 SECONDARY RESEARCH 31
2.1.1.1 Key secondary sources 31
2.1.1.2 Key data from secondary sources 32
2.1.1.3 Objectives of secondary research 32
2.1.2 PRIMARY RESEARCH 33
2.1.2.1 Key primary sources (demand and supply sides) 33
2.1.2.2 Supply- and demand-side participants 34
2.1.2.3 Breakdown of primary interviews: By company type, designation, and region 34
2.1.2.4 Objectives of primary research 34
2.1.2.5 Insights from industry experts 35
2.2 MARKET SIZE ESTIMATION 35
2.2.1 BOTTOM-UP APPROACH 37
2.2.1.1 Approach 1: Company revenue estimation 37
2.2.1.2 Approach 2: Customer-based market estimation 38
2.2.1.3 Approach 3: Primary interviews 39
2.2.2 BOTTOM-UP APPROACH 39
2.3 GROWTH RATE ASSUMPTIONS 40
2.4 DATA TRIANGULATION 42
2.5 RESEARCH ASSUMPTIONS 43
2.6 RESEARCH LIMITATIONS 43
2.7 RISK ASSESSMENT 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 48
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN COMPRESSION THERAPY MARKET 48
4.2 COMPRESSION THERAPY MARKET, BY REGION 49
4.3 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY AND
DISTRIBUTION CHANNEL 50
4.4 COMPRESSION THERAPY MARKET: GEOGRAPHIC SNAPSHOT 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
5.2.1 DRIVERS 53
5.2.1.1 Large target patient population 53
5.2.1.2 Growing incidence of sports injuries and accidents 54
5.2.1.3 Increasing number of orthopedic procedures 55
5.2.1.4 Greater product affordability and market availability 55
5.2.1.5 Clinical evidence favoring adoption of compression therapy for management of target conditions 56
5.2.2 RESTRAINTS 56
5.2.2.1 Lack of universally accepted standards for compression products 56
5.2.2.2 Low patient compliance with compression garments 57
5.2.3 OPPORTUNITIES 57
5.2.3.1 Growth potential offered by emerging markets 57
5.2.3.2 Growing patient awareness regarding benefits of compression therapy 58
5.2.4 CHALLENGES 58
5.2.4.1 Significant adoption of alternative therapies for specific target indications 58
5.2.4.2 Increasing pricing pressure on market players 59
5.3 PORTER’S FIVE FORCES ANALYSIS 60
5.3.1 THREAT OF NEW ENTRANTS 61
5.3.2 THREAT OF SUBSTITUTES 61
5.3.3 BARGAINING POWER OF SUPPLIERS 61
5.3.4 BARGAINING POWER OF BUYERS 61
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 61
5.4 REGULATORY ANALYSIS 62
5.4.1 REGULATORY ANALYSIS 62
5.4.1.1 US 62
5.4.1.2 Canada 63
5.4.1.3 Europe 63
5.4.1.4 Japan 64
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
5.5 REIMBURSEMENT SCENARIO 66
5.6 ECOSYSTEM ANALYSIS 67
5.7 INVESTMENT & FUNDING SCENARIO 68
5.8 TECHNOLOGY ANALYSIS 69
5.8.1 KEY TECHNOLOGIES 69
5.8.1.1 Pneumatic compression devices 69
5.8.1.2 Smart compression garments 69
5.8.1.3 Static compression devices 70
5.8.2 COMPLEMENTARY TECHNOLOGIES 70
5.8.2.1 Digital connectivity (telehealth platforms) 70
5.8.2.2 Value-added software (AI & IOT) 70
5.8.3 ADJACENT TECHNOLOGIES 70
5.8.3.1 Custom-fitted compression garments 70
5.9 VALUE CHAIN ANALYSIS 71
5.9.1 RESEARCH & DEVELOPMENT 71
5.9.2 RAW MATERIAL PROCUREMENT & PRODUCT MANUFACTURING 71
5.9.3 DISTRIBUTION, MARKETING & SALES, AND AFTER-SALES SERVICES 71
5.10 SUPPLY CHAIN ANALYSIS 72
5.10.1 PROMINENT COMPANIES 72
5.10.2 SMALL AND MEDIUM-SIZED ENTERPRISES 73
5.10.3 END USERS 73
5.11 PRICING ANALYSIS 73
5.11.1 AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE 74
5.11.2 AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY DEVICES,
BY PRODUCT TYPE, 2022–2024 75
5.11.3 AVERAGE SELLING PRICE TREND OF COMPRESSION STOCKINGS,
BY KEY PLAYER, 2022–2024 75
5.11.4 AVERAGE SELLING PRICE OF COMPRESSION STOCKINGS, BY KEY PLAYER, 2022–2024 76
5.11.5 AVERAGE SELLING PRICE TREND OF COMPRESSION BRACES,
BY KEY PLAYER, 2022–2024 76
5.11.6 AVERAGE SELLING PRICE OF COMPRESSION BRACES, BY KEY PLAYER, 2022–2024 76
5.11.7 AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY PRODUCTS,
BY REGION, 2022–2024 77
5.11.8 AVERAGE SELLING PRICE OF COMPRESSION THERAPY PRODUCTS,
BY REGION, 2022–2024 77
5.12 PATENT ANALYSIS 79
5.13 TRADE ANALYSIS 80
5.13.1 IMPORT SCENARIO (HS CODE 611510) 80
5.13.2 EXPORT SCENARIO (HS CODE 611510) 81
5.14 KEY CONFERENCES & EVENTS, 2025–2026 82
5.15 TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 83
5.16 KEY STAKEHOLDERS & BUYING CRITERIA 83
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 83
5.16.2 BUYING CRITERIA 85
5.17 UNMET NEEDS & KEY PAIN POINTS 86
5.18 IMPACT OF AI ON COMPRESSION THERAPY MARKET 87
5.19 IMPACT OF 2025 US TARIFF ON COMPRESSION THERAPY MARKET 87
5.19.1 INTRODUCTION 87
5.19.2 KEY TARIFF RATES 88
5.19.3 PRICE IMPACT ANALYSIS 88
5.19.4 IMPACT ON COUNTRY/REGION 89
5.19.4.1 US 89
5.19.4.2 Europe 89
5.19.4.3 Asia Pacific 90
5.19.5 IMPACT ON END-USE INDUSTRIES 90
6 COMPRESSION THERAPY MARKET, BY PRODUCT 91
6.1 INTRODUCTION 92
6.2 COMPRESSION BANDAGES 92
6.2.1 LIMITED AVAILABILITY OF MEDICAL REIMBURSEMENTS FOR VARICOSE VEIN SURGERIES TO RESTRAIN MARKET GROWTH 92
6.3 COMPRESSION WRAPS 97
6.3.1 RISING GERIATRIC POPULATION AND INCREASING INCIDENCE OF SPORTS INJURIES TO DRIVE MARKET 97
6.4 COMPRESSION STOCKINGS 102
6.4.1 CLASS I COMPRESSION STOCKINGS 107
6.4.1.1 Advantages such as comfort and durability to drive demand for Class I stockings 107
6.4.2 CLASS II COMPRESSION STOCKINGS 107
6.4.2.1 Increasing number of lymphedema and DVT patients to fuel demand 107
6.4.3 CLASS III COMPRESSION STOCKINGS 108
6.4.3.1 High level of compression provided to boost adoption of Class III stockings 108
6.5 COMPRESSION TAPES 109
6.5.1 ABILITY TO PREVENT FURTHER MUSCLE INJURY TO DRIVE DEMAND FOR COMPRESSION TAPES 109
6.6 PNEUMATIC COMPRESSION DEVICES 114
6.6.1 INTERMITTENT COMPRESSION DEVICES 120
6.6.1.1 Availability of wide range of intermittent pumps with varying designs and complexity to boost demand 120
6.6.2 SEQUENTIAL COMPRESSION DEVICES 120
6.6.2.1 Wide usage for DVT prevention to boost growth 120
6.7 COMPRESSION BRACES 121
6.7.1 RISING NUMBER OF JOINT REPLACEMENT SURGERIES TO SUPPORT MARKET 121
6.8 OTHER COMPRESSION GARMENTS 126
7 COMPRESSION THERAPY MARKET, BY TECHNIQUE 130
7.1 INTRODUCTION 131
7.2 STATIC COMPRESSION THERAPY 131
7.2.1 PROCEDURAL ADVANTAGES OF STATIC COMPRESSION THERAPY TO DRIVE GROWTH 131
7.3 DYNAMIC COMPRESSION THERAPY 132
7.3.1 RISING INCIDENCE OF TARGET CONDITIONS TO SUPPORT MARKET 132
8 COMPRESSION THERAPY MARKET, BY APPLICATION 134
8.1 INTRODUCTION 135
8.2 VARICOSE VEIN TREATMENT 135
8.2.1 GROWING GLOBAL PREVALENCE OF VARICOSE VEINS TO DRIVE MARKET 135
8.3 DEEP VEIN THROMBOSIS TREATMENT 136
8.3.1 AVAILABILITY OF ALTERNATIVE TREATMENTS FOR DVT TO LIMIT GROWTH 136
8.4 LYMPHEDEMA TREATMENT 137
8.4.1 RISING INCIDENCE OF CANCER TO CONTRIBUTE TO GROWTH 137
8.5 LEG ULCER TREATMENT 138
8.5.1 GROWING DISEASE BURDEN ACROSS MAJOR COUNTRIES TO BOOST MARKET 138
8.6 OTHER APPLICATIONS 139
9 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL 141
9.1 INTRODUCTION 142
9.2 PHARMACIES & RETAILERS 142
9.2.1 RISING ADOPTION OF OFF-THE-SHELF PRODUCTS TO SUPPORT MARKET GROWTH 142
9.3 E-COMMERCE PLATFORMS 143
9.3.1 E-COMMERCE PLATFORMS TO REGISTER HIGH CAGR DURING FORECAST PERIOD 143
9.4 HOSPITALS & CLINICS 144
9.4.1 HEALTHCARE INFRASTRUCTURAL IMPROVEMENTS TO BOOST GROWTH 144
9.5 HOME CARE SETTINGS 145
9.5.1 GROWING INCLINATION TOWARD HOME HEALTHCARE TO DRIVE MARKET 145
10 COMPRESSION THERAPY MARKET, BY REGION 147
10.1 INTRODUCTION 148
10.2 NORTH AMERICA 148
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 149
10.2.2 US 153
10.2.2.1 Rising number of sports injuries to drive market growth 153
10.2.3 CANADA 155
10.2.3.1 Increasing incidence of target diseases to support growth 155
10.3 EUROPE 156
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 157
10.3.2 GERMANY 160
10.3.2.1 Inconsistent reimbursement for compression therapy products to restrain market growth 160
10.3.3 FRANCE 162
10.3.3.1 High incidence of diabetes to drive demand for compression therapy 162
10.3.4 UK 163
10.3.4.1 Rising prevalence of lymphedema and DVT to drive market 163
10.3.5 ITALY 165
10.3.5.1 Rising awareness about preventive care for musculoskeletal injuries to fuel growth 165
10.3.6 SPAIN 166
10.3.6.1 Growing presence of key manufacturers to increase access to compression therapy products 166
10.3.7 REST OF EUROPE 167
10.4 ASIA PACIFIC 169
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 169
10.4.2 CHINA 174
10.4.2.1 Modernization of healthcare facilities to drive market growth 174
10.4.3 JAPAN 175
10.4.3.1 Japan to dominate Asia Pacific compression therapy market 175
10.4.4 INDIA 177
10.4.4.1 Growing number of hip & knee surgeries to support market 177
10.4.5 AUSTRALIA 179
10.4.5.1 Government subsidies related to compression garments for lymphedema patients to promote growth 179
10.4.6 SOUTH KOREA 180
10.4.6.1 Increasing number of plastic surgeries to drive demand for compression garments 180
10.4.7 REST OF ASIA PACIFIC 182
10.5 LATIN AMERICA 183
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 183
10.5.2 BRAZIL 186
10.5.2.1 Rising number of cosmetic surgeries to support market 186
10.5.3 MEXICO 188
10.5.3.1 Lack of reimbursement for bracing products to limit growth 188
10.5.4 REST OF LATIN AMERICA 189
10.6 MIDDLE EAST & AFRICA 190
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 191
10.6.2 GCC COUNTRIES 194
10.6.2.1 Significant investments in healthcare to boost growth 194
10.6.3 REST OF MIDDLE EAST & AFRICA 195
11 COMPETITIVE LANDSCAPE 196
11.1 INTRODUCTION 196
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2024 196
11.3 REVENUE ANALYSIS, 2020–2024 198
11.4 MARKET SHARE ANALYSIS, 2024 199
11.4.1 COMPRESSION STOCKINGS MARKET SHARE 199
11.4.2 COMPRESSION BANDAGES MARKET SHARE 200
11.4.3 PNEUMATIC COMPRESSION DEVICES MARKET SHARE 200
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 203
11.5.1 STARS 203
11.5.2 EMERGING LEADERS 203
11.5.3 PERVASIVE PLAYERS 204
11.5.4 PARTICIPANTS 204
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 205
11.5.5.1 Company footprint 205
11.5.5.2 Region footprint 206
11.5.5.3 Product footprint 206
11.5.5.4 Application footprint 207
11.5.5.5 Technique footprint 208
11.5.5.6 Distribution channel footprint 209
11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024 210
11.6.1 PROGRESSIVE COMPANIES 210
11.6.2 RESPONSIVE COMPANIES 210
11.6.3 DYNAMIC COMPANIES 210
11.6.4 STARTING BLOCKS 210
11.6.5 COMPANY BENCHMARKING: START-UPS/SMES, 2024 212
11.6.5.1 List of start-ups/SMEs 212
11.6.5.2 Competitive benchmarking of start-ups/SMEs 213
11.7 COMPANY VALUATION & FINANCIAL METRICS 214
11.8 PRODUCT/BRAND COMPARISON 215
11.9 COMPETITIVE SCENARIO 216
11.9.1 PRODUCT LAUNCHES & APPROVALS 216
11.9.2 DEALS 217
12 COMPANY PROFILES 219
12.1 KEY PLAYERS 219
12.1.1 SOLVENTUM CORPORATION (3M) 219
12.1.1.1 Business overview 219
12.1.1.2 Products offered 220
12.1.1.3 Recent developments 222
12.1.1.3.1 Product launches & approvals 222
12.1.1.3.2 Deals 222
12.1.1.4 MnM view 222
12.1.1.4.1 Key strengths 222
12.1.1.4.2 Strategic choices 223
12.1.1.4.3 Weaknesses & competitive threats 223
12.1.2 ENOVIS CORPORATION 224
12.1.2.1 Business overview 224
12.1.2.2 Products offered 225
12.1.2.3 Recent developments 226
12.1.2.3.1 Product launches 226
12.1.2.3.2 Deals 226
12.1.2.4 MnM view 227
12.1.2.4.1 Key strengths 227
12.1.2.4.2 Strategic choices 227
12.1.2.4.3 Weaknesses & competitive threats 227
12.1.3 BSN MEDICAL (A SUBSIDIARY OF ESSITY) 228
12.1.3.1 Business overview 228
12.1.3.2 Products offered 229
12.1.3.3 Recent developments 230
12.1.3.3.1 Deals 230
12.1.3.4 MnM view 230
12.1.3.4.1 Key strengths 230
12.1.3.4.2 Strategic choices 230
12.1.3.4.3 Weaknesses & competitive threats 231
12.1.4 CARDINAL HEALTH 232
12.1.4.1 Business overview 232
12.1.4.2 Products offered 233
12.1.4.3 Recent developments 234
12.1.4.3.1 Product launches & approvals 234
12.1.4.4 MnM view 234
12.1.4.4.1 Key strengths 234
12.1.4.4.2 Strategic choices 234
12.1.4.4.3 Weaknesses & competitive threats 235
12.1.5 ARJOHUNTLEIGH 236
12.1.5.1 Business overview 236
12.1.5.2 Products offered 237
12.1.5.3 MnM view 238
12.1.5.3.1 Key strengths 238
12.1.5.3.2 Strategic choices 238
12.1.5.3.3 Weaknesses & competitive threats 238
12.1.6 TACTILE MEDICAL 239
12.1.6.1 Business overview 239
12.1.6.2 Products offered 240
12.1.6.3 Recent developments 240
12.1.6.3.1 Product launches 240
12.1.7 CONVATEC INC. 241
12.1.7.1 Business overview 241
12.1.7.2 Products offered 242
12.1.7.3 Recent developments 243
12.1.7.3.1 Deals 243
12.1.8 BIO COMPRESSION SYSTEMS, INC. 244
12.1.8.1 Business overview 244
12.1.8.2 Products offered 244
12.1.9 JUZO GMBH 245
12.1.9.1 Business overview 245
12.1.9.2 Products offered 245
12.1.9.3 Recent developments 246
12.1.9.3.1 Product launches 246
12.1.10 MEDI GMBH & CO. KG 247
12.1.10.1 Business overview 247
12.1.10.2 Products offered 247
12.1.11 PAUL HARTMANN 249
12.1.11.1 Business overview 249
12.1.11.2 Products offered 250
12.1.11.3 Recent developments 251
12.1.11.3.1 Deals 251
12.1.12 SANYLEG, S.R.L. 252
12.1.12.1 Business overview 252
12.1.12.2 Products offered 252
12.1.13 SIGVARIS GROUP 254
12.1.13.1 Business overview 254
12.1.13.2 Products offered 254
12.1.13.3 Recent developments 255
12.1.13.3.1 Deals 255
12.1.14 SMITH+NEPHEW 256
12.1.14.1 Business overview 256
12.1.14.2 Products offered 257
12.1.14.3 Recent developments 258
12.1.14.3.1 Expansions 258
12.1.15 MEGO AFEK, LTD. 259
12.1.15.1 Business overview 259
12.1.15.2 Products offered 259
12.2 OTHER PLAYERS 261
12.2.1 GOTTFRIED MEDICAL, INC. 261
12.2.2 THERMOTEK, INC. 262
12.2.3 BAUERFEIND AG 263
12.2.4 OFA BAMBERG GMBH 264
12.2.5 MEDLINE INDUSTRIES 265
12.2.6 ACI MEDICAL 266
12.2.7 AIROS MEDICAL INC. 267
12.2.8 BARCELCOM TÊXTEIS, S.A 268
12.2.9 CIZETA MEDICALI S.P.A 269
12.2.10 BÖSL MEDIZINTECHNIK 270
13 APPENDIX 271
13.1 DISCUSSION GUIDE 271
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 275
13.3 CUSTOMIZATION OPTIONS 277
13.4 RELATED REPORTS 277
13.5 AUTHOR DETAILS 278
LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES 28
TABLE 2 PORTER’S FIVE FORCES ANALYSIS 60
TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
TABLE 6 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
TABLE 7 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
TABLE 8 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES 66
TABLE 9 AVERAGE SELLING PRICE OF COMPRESSION STOCKINGS, BY KEY PLAYER,
2022–2024 (USD) 76
TABLE 10 AVERAGE SELLING PRICE OF COMPRESSION BRACES, BY KEY PLAYER,
2022–2024 (USD) 76
TABLE 11 AVERAGE SELLING PRICE OF COMPRESSION THERAPY PRODUCT TYPE, BY REGION, 2022–2024 77
TABLE 12 COMPRESSION THERAPY MARKET: LIST OF MAJOR PATENTS 80
TABLE 13 IMPORT DATA FOR HS CODE 611510, BY COUNTRY,
2020–2024 (USD THOUSAND) 81
TABLE 14 EXPORT DATA FOR HS CODE 611510, BY COUNTRY,
2020–2024 (USD THOUSAND) 82
TABLE 15 COMPRESSION THERAPY MARKET: KEY CONFERENCES & EVENTS, 2025–2026 82
TABLE 16 KEY REQUIREMENTS OF STAKEHOLDERS WHILE BUYING COMPRESSION
THERAPY PRODUCTS 84
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COMPRESSION
THERAPY PRODUCTS (%) 85
TABLE 18 UNMET CUSTOMER NEEDS & KEY PAIN POINTS 86
TABLE 19 US-ADJUSTED RECIPROCAL TARIFF RATES 88
TABLE 20 COMPRESSION THERAPY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 92
TABLE 21 COMPRESSION BANDAGES MARKET, BY REGION, 2023–2030 (USD MILLION) 93
TABLE 22 NORTH AMERICA: COMPRESSION BANDAGES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 93
TABLE 23 EUROPE: COMPRESSION BANDAGES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 94
TABLE 24 ASIA PACIFIC: COMPRESSION BANDAGES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 94
TABLE 25 LATIN AMERICA: COMPRESSION BANDAGES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 95
TABLE 26 MIDDLE EAST & AFRICA: COMPRESSION BANDAGES MARKET, BY REGION,
2023–2030 (USD MILLION) 95
TABLE 27 COMPRESSION BANDAGES MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 95
TABLE 28 COMPRESSION BANDAGES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 96
TABLE 29 COMPRESSION BANDAGES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 96
TABLE 30 COMPRESSION WRAPS MARKET, BY REGION, 2023–2030 (USD MILLION) 97
TABLE 31 NORTH AMERICA: COMPRESSION WRAPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 98
TABLE 32 EUROPE: COMPRESSION WRAPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 98
TABLE 33 ASIA PACIFIC: COMPRESSION WRAPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 99
TABLE 34 LATIN AMERICA: COMPRESSION WRAPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 99
TABLE 35 MIDDLE EAST & AFRICA: COMPRESSION WRAPS MARKET, BY REGION,
2023–2030 (USD MILLION) 100
TABLE 36 COMPRESSION WRAPS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 100
TABLE 37 COMPRESSION WRAPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 101
TABLE 38 COMPRESSION WRAPS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 101
TABLE 39 COMPRESSION STOCKINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 102
TABLE 40 COMPRESSION STOCKINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 103
TABLE 41 NORTH AMERICA: COMPRESSION STOCKINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 103
TABLE 42 EUROPE: COMPRESSION STOCKINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 104
TABLE 43 ASIA PACIFIC: COMPRESSION STOCKINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 104
TABLE 44 LATIN AMERICA: COMPRESSION STOCKINGS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 105
TABLE 45 MIDDLE EAST & AFRICA: COMPRESSION STOCKINGS MARKET, BY REGION,
2023–2030 (USD MILLION) 105
TABLE 46 COMPRESSION STOCKINGS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 105
TABLE 47 COMPRESSION STOCKINGS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 106
TABLE 48 COMPRESSION STOCKINGS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 106
TABLE 49 CLASS I COMPRESSION STOCKINGS MARKET, BY REGION,
2023–2030 (USD MILLION) 107
TABLE 50 CLASS II COMPRESSION STOCKINGS MARKET, BY REGION,
2023–2030 (USD MILLION) 108
TABLE 51 CLASS III COMPRESSION STOCKINGS MARKET, BY REGION,
2023–2030 (USD MILLION) 109
TABLE 52 COMPRESSION TAPES MARKET, BY REGION, 2023–2030 (USD MILLION) 109
TABLE 53 NORTH AMERICA: COMPRESSION TAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 110
TABLE 54 EUROPE: COMPRESSION TAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 110
TABLE 55 ASIA PACIFIC: COMPRESSION TAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 56 LATIN AMERICA: COMPRESSION TAPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 57 MIDDLE EAST & AFRICA: COMPRESSION TAPES MARKET, BY REGION,
2023–2030 (USD MILLION) 112
TABLE 58 COMPRESSION TAPES MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 112
TABLE 59 COMPRESSION TAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 113
TABLE 60 COMPRESSION TAPES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 113
TABLE 61 PNEUMATIC COMPRESSION DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 115
TABLE 62 PNEUMATIC COMPRESSION DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 115
TABLE 63 NORTH AMERICA: PNEUMATIC COMPRESSION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 64 EUROPE: PNEUMATIC COMPRESSION DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 116
TABLE 65 ASIA PACIFIC: PNEUMATIC COMPRESSION DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 117
TABLE 66 LATIN AMERICA: PNEUMATIC COMPRESSION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 67 MIDDLE EAST & AFRICA: PNEUMATIC COMPRESSION DEVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 118
TABLE 68 PNEUMATIC COMPRESSION DEVICES MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 118
TABLE 69 PNEUMATIC COMPRESSION DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 119
TABLE 70 PNEUMATIC COMPRESSION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 119
TABLE 71 INTERMITTENT COMPRESSION DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 120
TABLE 72 SEQUENTIAL COMPRESSION DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 121
TABLE 73 COMPRESSION BRACES MARKET, BY REGION, 2023–2030 (USD MILLION) 122
TABLE 74 NORTH AMERICA: COMPRESSION BRACES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 122
TABLE 75 EUROPE: COMPRESSION BRACES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 123
TABLE 76 ASIA PACIFIC:COMPRESSION BRACES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 123
TABLE 77 LATIN AMERICA: COMPRESSION BRACES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 124
TABLE 78 MIDDLE EAST & AFRICA: COMPRESSION BRACES, BY REGION,
2023–2030 (USD MILLION) 124
TABLE 79 COMPRESSION BRACES MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 124
TABLE 80 COMPRESSION BRACES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 125
TABLE 81 COMPRESSION BRACES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 125
TABLE 82 OTHER COMPRESSION GARMENTS MARKET, BY REGION,
2023–2030 (USD MILLION) 126
TABLE 83 NORTH AMERICA: OTHER COMPRESSION GARMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 84 EUROPE: OTHER COMPRESSION GARMENTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 127
TABLE 85 ASIA PACIFIC: OTHER COMPRESSION GARMENTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 127
TABLE 86 LATIN AMERICA: OTHER COMPRESSION GARMENTS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 128
TABLE 87 MIDDLE EAST & AFRICA: OTHER COMPRESSION GARMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 128
TABLE 88 OTHER COMPRESSION GARMENTS MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 128
TABLE 89 OTHER COMPRESSION GARMENTS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 129
TABLE 90 OTHER COMPRESSION GARMENTS MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 129
TABLE 91 COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 131
TABLE 92 STATIC COMPRESSION THERAPY MARKET, BY REGION,
2023–2030 (USD MILLION) 132
TABLE 93 DYNAMIC COMPRESSION THERAPY MARKET, BY REGION,
2023–2030 (USD MILLION) 133
TABLE 94 COMPRESSION THERAPY MARKET, BY APPLICATION, 2023–2030(USD MILLION) 135
TABLE 95 COMPRESSION THERAPY MARKET FOR VARICOSE VEIN TREATMENT, BY REGION, 2023–2030 (USD MILLION) 136
TABLE 96 COMPRESSION THERAPY MARKET FOR DEEP VEIN THROMBOSIS TREATMENT,
BY REGION, 2023–2030 (USD MILLION) 137
TABLE 97 COMPRESSION THERAPY MARKET FOR LYMPHEDEMA TREATMENT, BY REGION, 2023–2030 (USD MILLION) 138
TABLE 98 COMPRESSION THERAPY MARKET FOR LEG ULCER TREATMENT, BY REGION, 2023–2030 (USD MILLION) 139
TABLE 99 COMPRESSION THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION,
2023–2030 (USD MILLION) 140
TABLE 100 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 142
TABLE 101 COMPRESSION THERAPY MARKET FOR PHARMACIES & RETAILERS, BY REGION, 2023–2030 (USD MILLION) 143
TABLE 102 COMPRESSION THERAPY MARKET FOR E-COMMERCE PLATFORMS, BY REGION, 2023–2030 (USD MILLION) 144
TABLE 103 COMPRESSION THERAPY MARKET FOR HOSPITALS & CLINICS, BY REGION,
2023–2030 (USD MILLION) 145
TABLE 104 COMPRESSION THERAPY MARKET FOR HOME CARE SETTINGS, BY REGION,
2023–2030 (USD MILLION) 146
TABLE 105 COMPRESSION THERAPY MARKET, BY REGION, 2023–2030 (USD MILLION) 148
TABLE 106 NORTH AMERICA: MACROECONOMIC INDICATORS 149
TABLE 107 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 151
TABLE 108 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 151
TABLE 109 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 152
TABLE 110 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 152
TABLE 111 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 153
TABLE 112 US: KEY MACROINDICATORS 154
TABLE 113 US: COMPRESSION THERAPY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 154
TABLE 114 CANADA: KEY MACROINDICATORS 155
TABLE 115 CANADA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 156
TABLE 116 EUROPE: MACROECONOMIC INDICATORS 157
TABLE 117 EUROPE: COMPRESSION THERAPY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 158
TABLE 118 EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 158
TABLE 119 EUROPE: COMPRESSION THERAPY MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 159
TABLE 120 EUROPE: COMPRESSION THERAPY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 159
TABLE 121 EUROPE: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 160
TABLE 122 GERMANY: KEY MACROINDICATORS 161
TABLE 123 GERMANY: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 161
TABLE 124 FRANCE: KEY MACROINDICATORS 162
TABLE 125 FRANCE: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 163
TABLE 126 UK: KEY MACROINDICATORS 164
TABLE 127 UK: COMPRESSION THERAPY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 164
TABLE 128 ITALY: KEY MACROINDICATORS 165
TABLE 129 ITALY: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 166
TABLE 130 SPAIN: KEY MACROINDICATORS 167
TABLE 131 SPAIN: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 167
TABLE 132 HIP SURGERY PROCEDURES (TOTAL PATIENTS) IN EUROPEAN COUNTRIES 168
TABLE 133 REST OF EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 168
TABLE 134 ASIA PACIFIC: MACROECONOMIC INDICATORS 170
TABLE 135 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 172
TABLE 136 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 172
TABLE 137 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 173
TABLE 138 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 173
TABLE 139 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 174
TABLE 140 CHINA: KEY MACROINDICATORS 175
TABLE 141 CHINA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 175
TABLE 142 JAPAN: KEY MACROINDICATORS 176
TABLE 143 JAPAN: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 177
TABLE 144 INDIA: KEY MACROINDICATORS 178
TABLE 145 INDIA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 178
TABLE 146 AUSTRALIA: KEY MACROINDICATORS 179
TABLE 147 AUSTRALIA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 180
TABLE 148 SOUTH KOREA: KEY MACROINDICATORS 181
TABLE 149 SOUTH KOREA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 181
TABLE 150 REST OF ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 182
TABLE 151 LATIN AMERICA: MACROECONOMIC INDICATORS 183
TABLE 152 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 184
TABLE 153 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 184
TABLE 154 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE,
2023–2030 (USD MILLION) 185
TABLE 155 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 185
TABLE 156 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 186
TABLE 157 BRAZIL: KEY MACROINDICATORS 187
TABLE 158 BRAZIL: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 187
TABLE 159 MEXICO: KEY MACROINDICATORS 188
TABLE 160 MEXICO: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 189
TABLE 161 REST OF LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 190
TABLE 162 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 191
TABLE 163 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY REGION,
2023–2030 (USD MILLION) 191
TABLE 164 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 192
TABLE 165 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 192
TABLE 166 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 193
TABLE 167 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET,
BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 193
TABLE 168 GCC COUNTRIES: COMPRESSION THERAPY MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 194
TABLE 169 REST OF MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 195
TABLE 170 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN
COMPRESSION THERAPY MARKET 197
TABLE 171 COMPRESSION THERAPY MARKET: DEGREE OF COMPETITION 202
TABLE 172 COMPRESSION THERAPY MARKET: REGION FOOTPRINT 206
TABLE 173 COMPRESSION THERAPY MARKET: PRODUCT FOOTPRINT 206
TABLE 174 COMPRESSION THERAPY MARKET: APPLICATION FOOTPRINT 207
TABLE 175 COMPRESSION THERAPY MARKET: TECHNIQUE FOOTPRINT 208
TABLE 176 COMPRESSION THERAPY MARKET: DISTRIBUTION CHANNEL FOOTPRINT 209
TABLE 177 LIST OF KEY START-UPS/SMES 212
TABLE 178 COMPETITIVE BENCHMARKING OF START-UPS/SMES 213
TABLE 179 COMPRESSION THERAPY MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–APRIL 2025 216
TABLE 180 COMPRESSION THERAPY MARKET: DEALS, JANUARY 2021–APRIL 2025 217
TABLE 181 SOLVENTUM CORPORATION: COMPANY OVERVIEW 219
TABLE 182 SOLVENTUM CORPORATION (3M): PRODUCTS OFFERED 220
TABLE 183 SOLVENTUM CORPORATION (3M): PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–APRIL 2025 222
TABLE 184 SOLVENTUM CORPORATION (3M): DEALS, JANUARY 2021–APRIL 2025 222
TABLE 185 ENOVIS CORPORATION: COMPANY OVERVIEW 224
TABLE 186 ENOVIS CORPORATION: PRODUCTS OFFERED 225
TABLE 187 ENOVIS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 226
TABLE 188 ENOVIS CORPORATION: DEALS, JANUARY 2021–APRIL 2025 226
TABLE 189 ESSITY: COMPANY OVERVIEW 228
TABLE 190 ESSITY: PRODUCTS OFFERED 229
TABLE 191 ESSITY: DEALS, JANUARY 2021–APRIL 2025 230
TABLE 192 CARDINAL HEALTH: COMPANY OVERVIEW 232
TABLE 193 CARDINAL HEALTH: PRODUCTS OFFERED 233
TABLE 194 CARDINAL HEALTH: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–APRIL 2025 234
TABLE 195 ARJOHUNTLEIGH: COMPANY OVERVIEW 236
TABLE 196 ARJOHUNTLEIGH: PRODUCTS OFFERED 237
TABLE 197 TACTILE MEDICAL: COMPANY OVERVIEW 239
TABLE 198 TACTILE MEDICAL: PRODUCTS OFFERED 240
TABLE 199 TACTILE MEDICAL: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 240
TABLE 200 CONVATEC INC.: COMPANY OVERVIEW 241
TABLE 201 CONVATEC INC.: PRODUCTS OFFERED 242
TABLE 202 CONVATEC INC.: DEALS, JANUARY 2021–APRIL 2025 243
TABLE 203 BIO COMPRESSION SYSTEMS, INC.: COMPANY OVERVIEW 244
TABLE 204 BIO COMPRESSION SYSTEMS, INC.: PRODUCTS OFFERED 244
TABLE 205 JUZO GMBH: COMPANY OVERVIEW 245
TABLE 206 JUZO GMBH: PRODUCTS OFFERED 245
TABLE 207 JUZO GMBH: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025 246
TABLE 208 MEDI GMBH & CO. KG: COMPANY OVERVIEW 247
TABLE 209 MEDI GMBH & CO. KG: PRODUCTS OFFERED 247
TABLE 210 PAUL HARTMANN: COMPANY OVERVIEW 249
TABLE 211 PAUL HARTMANN: PRODUCTS OFFERED 250
TABLE 212 PAUL HARTMANN: DEALS, JANUARY 2021–APRIL 2025 251
TABLE 213 SANYLEG, S.R.L.: COMPANY OVERVIEW 252
TABLE 214 SANYLEG, S.R.L.: PRODUCTS OFFERED 252
TABLE 215 SIGVARIS GROUP: COMPANY OVERVIEW 254
TABLE 216 SIGVARIS GROUP: PRODUCTS OFFERED 254
TABLE 217 SIGVARIS GROUP.: DEALS, JANUARY 2021–APRIL 2025 255
TABLE 218 SMITH+NEPHEW: COMPANY OVERVIEW 256
TABLE 219 SMITH+NEPHEW: PRODUCTS OFFERED 257
TABLE 220 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021–APRIL 2025 258
TABLE 221 MEGO AFEK, LTD.: COMPANY OVERVIEW 259
TABLE 222 MEGO AFEK, LTD.: PRODUCTS OFFERED 259
TABLE 223 GOTTFRIED MEDICAL, INC.: COMPANY OVERVIEW 261
TABLE 224 THERMOTEK, INC.: COMPANY OVERVIEW 262
TABLE 225 BAUERFEIND AG: COMPANY OVERVIEW 263
TABLE 226 OFA BAMBERG GMBH: COMPANY OVERVIEW 264
TABLE 227 MEDLINE INDUSTRIES: COMPANY OVERVIEW 265
TABLE 228 ACI MEDICAL: COMPANY OVERVIEW 266
TABLE 229 AIROS MEDICAL INC.: COMPANY OVERVIEW 267
TABLE 230 BARCELCOM TÊXTEIS, S.A: COMPANY OVERVIEW 268
TABLE 231 CIZETA MEDICALI S.P.A: COMPANY OVERVIEW 269
TABLE 232 BÖSL MEDIZINTECHNIK: COMPANY OVERVIEW 270
LIST OF FIGURES
FIGURE 1 COMPRESSION THERAPY MARKET SEGMENTATION & REGIONAL SCOPE 26
FIGURE 2 COMPRESSION THERAPY MARKET: RESEARCH DATA 30
FIGURE 3 COMPRESSION THERAPY MARKET: RESEARCH DESIGN 31
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 36
FIGURE 5 MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION 37
FIGURE 6 COMPRESSION THERAPY MARKET: MARKET SIZE ESTIMATION METHODOLOGY 38
FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 39
FIGURE 8 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACROINDICATORS 41
FIGURE 9 DATA TRIANGULATION 42
FIGURE 10 COMPRESSION THERAPY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 44
FIGURE 11 COMPRESSION THERAPY MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 45
FIGURE 12 COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION) 46
FIGURE 13 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL,
2025 VS. 2030 (USD MILLION) 46
FIGURE 14 COMPRESSION THERAPY MARKET: GEOGRAPHIC OUTLOOK 47
FIGURE 15 GROWING INCIDENCE OF SPORTS INJURIES AND FAVORABLE CLINICAL EVIDENCE TO DRIVE MARKET GROWTH 48
FIGURE 16 ASIA PACIFIC TO BE FASTEST-GROWING MARKET FOR COMPRESSION
THERAPY DURING FORECAST PERIOD 49
FIGURE 17 HOSPITALS & CLINICS AND US WERE LARGEST SEGMENTS IN 2024 50
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 51
FIGURE 19 COMPRESSION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 52
FIGURE 20 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050 53
FIGURE 21 EUROPE: ROAD DEATHS PER MILLION INHABITANTS, BY COUNTRY, 2021 54
FIGURE 22 REASONS FOR NON-COMPLIANCE WITH COMPRESSION THERAPY 57
FIGURE 23 PORTER’S FIVE FORCES ANALYSIS 60
FIGURE 24 COMPRESSION THERAPY MARKET: ECOSYSTEM ANALYSIS 67
FIGURE 25 COMPRESSION THERAPY MARKET: INVESTMENT & FUNDING SCENARIO,
2019–2023 (USD MILLION) 68
FIGURE 26 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 68
FIGURE 27 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 69
FIGURE 28 COMPRESSION THERAPY MARKET: VALUE CHAIN ANALYSIS 72
FIGURE 29 COMPRESSION THERAPY MARKET: SUPPLY CHAIN ANALYSIS 73
FIGURE 30 AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY PRODUCTS,
BY TYPE, 2022–2024 (USD THOUSAND) 74
FIGURE 31 AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY MARKET,
BY PRODUCT TYPE, 2022–2024 (USD) 75
FIGURE 32 AVERAGE SELLING PRICE TREND OF COMPRESSION STOCKINGS, BY KEY PLAYER, 2022–2024 (USD THOUSAND) 75
FIGURE 33 AVERAGE SELLING PRICE TREND OF COMPRESSION BRACES, BY KEY PLAYER, 2022–2024 (USD THOUSAND) 76
FIGURE 34 AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY PRODUCTS,
BY REGION, 2022–2024 (USD THOUSAND) 77
FIGURE 35 COMPRESSION THERAPY MARKET: PATENT ANALYSIS 79
FIGURE 36 COMPRESSION THERAPY MARKET: IMPORT SCENARIO FOR HS CODE 611510, 2020–2024 80
FIGURE 37 COMPRESSION THERAPY MARKET: EXPORT SCENARIO FOR HS CODE 611510, 2020–2024 81
FIGURE 38 TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 83
FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COMPRESSION
THERAPY PRODUCTS 84
FIGURE 40 KEY BUYING CRITERIA FOR TOP THREE END USERS 85
FIGURE 41 NORTH AMERICA: COMPRESSION THERAPY MARKET SNAPSHOT 150
FIGURE 42 ASIA PACIFIC: COMPRESSION THERAPY MARKET SNAPSHOT 171
FIGURE 43 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN COMPRESSION THERAPY MARKET, 2020–2024 199
FIGURE 44 COMPRESSION STOCKINGS MARKET SHARE ANALYSIS, 2024 200
FIGURE 45 COMPRESSION BANDAGES MARKET SHARE ANALYSIS, 2024 200
FIGURE 46 PNEUMATIC COMPRESSION DEVICES MARKET SHARE ANALYSIS, 2024 201
FIGURE 47 COMPRESSION THERAPY MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 204
FIGURE 48 COMPRESSION THERAPY MARKET: COMPANY FOOTPRINT 205
FIGURE 49 COMPRESSION THERAPY MARKET: COMPANY EVALUATION MATRIX
(START-UPS/SMES), 2024 211
FIGURE 50 EV/EBITDA OF KEY VENDORS 214
FIGURE 51 5-YEAR STOCK BETA OF KEY VENDORS 214
FIGURE 52 BRAND/PRODUCT COMPARATIVE ANALYSIS 215
FIGURE 53 SOLVENTUM CORPORATION: COMPANY SNAPSHOT (2024) 220
FIGURE 54 ENOVIS CORPORATION: COMPANY SNAPSHOT (2024) 225
FIGURE 55 ESSITY: COMPANY SNAPSHOT (2024) 229
FIGURE 56 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 233
FIGURE 57 ARJOHUNTLEIGH: COMPANY SNAPSHOT (2024) 237
FIGURE 58 TACTILE MEDICAL: COMPANY SNAPSHOT (2024) 239
FIGURE 59 CONVATEC INC.: COMPANY SNAPSHOT (2024) 242
FIGURE 60 PAUL HARTMANN: COMPANY SNAPSHOT (2024) 250
FIGURE 61 SMITH+NEPHEW: COMPANY SNAPSHOT (2024) 257
MarketsandMarkets(マーケッツアンドマーケッツ)は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間~12時間以内(営業日基準)にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
USD8,150 | USD9,150 | USD9,650 | USD11,500 |
ライセンスタイプ4
シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
シングルユーザ | コーポレート |
USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内(関連会社除く)5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100%持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内(営業日基準)
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- LNGステーション市場 – 2030年までの世界予測 2025-06-16
- アジア太平洋(APAC)ミサイル市場 – 2030年までの地域予測 2025-06-13
- 高圧洗浄機市場 – 2030年までの世界予測 2025-06-12
- 装甲車両市場 – 2030年までの世界予測 2025-06-12
- 工業用ゴム市場 – 2030年までの世界予測 2025-06-12